NR1H4 and Insulin resistance: Studies using whole-body FXR knockout mice have shown a reduction in insulin sensitivity, whereas administration of the FXR agonist GW4064 significantly improves insulin resistance and glucose regulation in ob/ob mice (Cariou et al., 2006).